346 related articles for article (PubMed ID: 12800480)
1. Insulin therapy for the critically ill patient.
Van den Berghe G
Clin Cornerstone; 2003; 5(2):56-63. PubMed ID: 12800480
[TBL] [Abstract][Full Text] [Related]
2. Beyond diabetes: saving lives with insulin in the ICU.
Van den Berghe G
Int J Obes Relat Metab Disord; 2002 Sep; 26 Suppl 3():S3-8. PubMed ID: 12174317
[TBL] [Abstract][Full Text] [Related]
3. Role of intravenous insulin therapy in critically ill patients.
Van den Berghe GH
Endocr Pract; 2004; 10 Suppl 2():17-20. PubMed ID: 15251636
[TBL] [Abstract][Full Text] [Related]
4. Intensive insulin therapy in critically ill patients.
van den Berghe G; Wouters P; Weekers F; Verwaest C; Bruyninckx F; Schetz M; Vlasselaers D; Ferdinande P; Lauwers P; Bouillon R
N Engl J Med; 2001 Nov; 345(19):1359-67. PubMed ID: 11794168
[TBL] [Abstract][Full Text] [Related]
5. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.
Van den Berghe G; Wouters PJ; Bouillon R; Weekers F; Verwaest C; Schetz M; Vlasselaers D; Ferdinande P; Lauwers P
Crit Care Med; 2003 Feb; 31(2):359-66. PubMed ID: 12576937
[TBL] [Abstract][Full Text] [Related]
6. Design and rationale of Heart and Lung Failure - Pediatric INsulin Titration Trial (HALF-PINT): A randomized clinical trial of tight glycemic control in hyperglycemic critically ill children.
Agus MS; Hirshberg E; Srinivasan V; Faustino EV; Luckett PM; Curley MA; Alexander J; Asaro LA; Coughlin-Wells K; Duva D; French J; Hasbani N; Sisko MT; Soto-Rivera CL; Steil G; Wypij D; Nadkarni VM
Contemp Clin Trials; 2017 Feb; 53():178-187. PubMed ID: 28042054
[TBL] [Abstract][Full Text] [Related]
7. Glucose control in the intensive care unit.
Fahy BG; Sheehy AM; Coursin DB
Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
[TBL] [Abstract][Full Text] [Related]
8. Clinical potential of insulin therapy in critically ill patients.
Mesotten D; Van den Berghe G
Drugs; 2003; 63(7):625-36. PubMed ID: 12656643
[TBL] [Abstract][Full Text] [Related]
9. Performance of a dose-defining insulin infusion protocol among trauma service intensive care unit admissions.
Braithwaite SS; Edkins R; Macgregor KL; Sredzienski ES; Houston M; Zarzaur B; Rich PB; Benedetto B; Rutherford EJ
Diabetes Technol Ther; 2006 Aug; 8(4):476-88. PubMed ID: 16939372
[TBL] [Abstract][Full Text] [Related]
10. Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients.
Chant C; Wilson G; Friedrich JO
Pharmacotherapy; 2005 Mar; 25(3):352-9. PubMed ID: 15843282
[TBL] [Abstract][Full Text] [Related]
11. [Clinical study of the month. Toxicity of hyperglycemia in intensive care and beneficial effects of optimized insulin therapy].
Scheen AJ
Rev Med Liege; 2001 Dec; 56(12):859-61. PubMed ID: 11820041
[TBL] [Abstract][Full Text] [Related]
12. Implementation of tight glucose control for critically ill surgical patients: a process improvement analysis.
Eachempati SR; Hydo LJ; Shou J; Barie PS
Surg Infect (Larchmt); 2009 Dec; 10(6):523-31. PubMed ID: 20001333
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients.
Mesejo A; Acosta JA; Ortega C; Vila J; Fernández M; Ferreres J; Sanchis JC; López F
Clin Nutr; 2003 Jun; 22(3):295-305. PubMed ID: 12765670
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia in Critically Ill Patients: Management and Prognosis.
Godinjak A; Iglica A; Burekovic A; Jusufovic S; Ajanovic A; Tancica I; Kukuljac A
Med Arch; 2015 Jun; 69(3):157-60. PubMed ID: 26261382
[TBL] [Abstract][Full Text] [Related]
15. Intensive insulin therapy in practice: can we do it?
Dossett LA; Collier B; Donahue R; Mowery NT; Dortch MJ; Guillamondegui O; Diaz JJ; May AK
JPEN J Parenter Enteral Nutr; 2009; 33(1):14-20. PubMed ID: 18832598
[TBL] [Abstract][Full Text] [Related]
16. Software-guided versus nurse-directed blood glucose control in critically ill patients: the LOGIC-2 multicenter randomized controlled clinical trial.
Dubois J; Van Herpe T; van Hooijdonk RT; Wouters R; Coart D; Wouters P; Van Assche A; Veraghtert G; De Moor B; Wauters J; Wilmer A; Schultz MJ; Van den Berghe G; Mesotten D
Crit Care; 2017 Aug; 21(1):212. PubMed ID: 28806982
[TBL] [Abstract][Full Text] [Related]
17. Intensive insulin therapy for critically ill patients.
Lewis KS; Kane-Gill SL; Bobek MB; Dasta JF
Ann Pharmacother; 2004; 38(7-8):1243-51. PubMed ID: 15187219
[TBL] [Abstract][Full Text] [Related]
18. Intensive versus conventional glucose control in critically ill patients.
; Finfer S; Chittock DR; Su SY; Blair D; Foster D; Dhingra V; Bellomo R; Cook D; Dodek P; Henderson WR; Hébert PC; Heritier S; Heyland DK; McArthur C; McDonald E; Mitchell I; Myburgh JA; Norton R; Potter J; Robinson BG; Ronco JJ
N Engl J Med; 2009 Mar; 360(13):1283-97. PubMed ID: 19318384
[TBL] [Abstract][Full Text] [Related]
19. Improved safety with intravenous insulin therapy for critically ill patients with renal failure.
Dickerson RN; Lynch AM; Maish GO; Croce MA; Minard G; Brown RO
Nutrition; 2014 May; 30(5):557-62. PubMed ID: 24296035
[TBL] [Abstract][Full Text] [Related]
20. Improving IV insulin administration in a community hospital.
Magee MC
J Vis Exp; 2012 Jun; (64):e3705. PubMed ID: 22710978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
